Uncategorized

Reading Time: 5 minutesAclairo® Pharmaceutical Development Group, Inc. is committed to delivering independent and objective nonclinical and regulatory advice to the pharmaceutical industry. Every member of Aclairo’s staff strives to provide our clients with superior advice, analysis, work product and program assistance. Aclairo’s unique experience and capabilities help our clients’ development programs succeed. Our senior consultants are experienced ex-FDA […]

Reading Time: < 1 minuteThe Standard for Exchange of Nonclinical Data (SEND) provides preclinical study data standards that will allow for a more consistent and streamlined review process by the US FDA.  In general, SEND formats apply to studies started after Dec. 17, 2016 for NDAs, BLAs, and ANDAs, and studies that start after Dec. 17, 2017 for INDs.

Reading Time: 2 minutesEPL is pleased to announce that our veterinary pathology staff will once again be associated with multiple presentations and scientific posters at The 36th Society of Toxicologic Pathology (STP) Annual Symposium to be held in Montreal, Quebec from June 24-29, 2017.  The focus of this year’s symposium is the musculoskeletal system. EPL will have three pathologists

Reading Time: < 1 minuteDr. Tom Steinbach from EPL will be the featured speaker for the Webinar titled, “Using Electron Microscopy in Nonclinical Studies,” which is jointly sponsored by the Society of Toxicologic Pathology-India (STP-I), International Federation of Societies of Toxicologic Pathologists (IFSTP), and International Academy of Toxicologic Pathology (IATP). This webinar will be held on Thursday, May 25,

Reading Time: < 1 minuteDr. Jeff Wolf from EPL will be participating as a chair and speaker at the 2017 STP Regional Meeting focusing on Environmental Toxicologic Pathology.  The event is organized by the Society of Toxicologic Pathology’s Environmental Toxicologic Pathology Special Interest Group (ETP–SIG) and will be held at the National Toxicology Program/NIEHS Headquarters in Research Triangle Park,

Reading Time: 2 minutesExperimental Pathology Laboratories, Inc. (EPL), and West China-Frontier PharmaTech Co., Ltd. (WCFP) announce a Strategic Alliance to enhance Preclinical Services. This alliance is targeted to bolster the rapid growth of WCFP by specifically providing EPL’s Pathology Peer Review Services for WCFP projects that are being submitted to international regulatory agencies. WCFP is experiencing rapid growth

Reading Time: 4 minutesExperimental Pathology Laboratories, Inc. (EPL), Aclairo Pharmaceutical Development Group, Inc. (Alcairo), and Dr. Ada H.C. Kung with Expedient Solutions International (ESI) announce a new strategic alliance to enhance Preclinical Pathology and Regulatory Consulting Services to the Greater China pharmaceutical and biotechnology industry.  This alliance is targeted to expand and enhance EPL, Aclairo, and ESI’s capabilities

Reading Time: 2 minutesExperimental Pathology Laboratories, Inc. (EPL®) is proud to announce that Dr. Paul Snyder has been elected as President of the Society of Toxicologic Pathology (STP).  He will begin serving on the Executive Committee starting in June 2017 along with Mark J. Hoenerhoff (NIEHS) and Stacey Fossey (AbbVie) who will serve four-year terms as Councilors.  Dr.

Reading Time: < 1 minuteEPL will once again be exhibiting at ToxExpo™ in Baltimore from March 13-15, 2017.  If you are attending the 56th Annual Society of Toxicology Meeting, please visit our teams from EPL and Aclairo; we will be exhibiting in Booth #2332. Please stop by and visit EPL if you are in Baltimore!  For more information about the SOT,

Reading Time: < 1 minuteEPL is pleased to announce that Dr. Tom Steinbach will serve as Vice President of EPL, Inc.  As EPL Vice President, Dr. Steinbach will work with EPL’s President and other corporate officers to formulate and implement EPL’s strategic goals.  He will continue to oversee all operations in EPL’s North Carolina facility and manage EPL’s largest